A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials
Authors
Keywords
-
Journal
DRUG SAFETY
Volume 41, Issue 8, Pages 807-816
Publisher
Springer Nature
Online
2018-05-08
DOI
10.1007/s40264-018-0669-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy
- (2015) Tuan Dong-Si et al. JOURNAL OF NEUROVIROLOGY
- Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Tatiana Plavina et al. ANNALS OF NEUROLOGY
- Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
- (2014) Bruce E. Sands et al. GASTROENTEROLOGY
- Inflammatory bowel disease: An increased risk factor for neurologic complications
- (2014) Germán Morís WORLD JOURNAL OF GASTROENTEROLOGY
- Outcome and survival of asymptomatic PML in natalizumab-treated MS patients
- (2014) Tuan Dong-Si et al. Annals of Clinical and Translational Neurology
- Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease
- (2013) Asit Parikh et al. INFLAMMATORY BOWEL DISEASES
- PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section
- (2013) J. R. Berger et al. NEUROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
- (2012) Eric R. Fedyk et al. INFLAMMATORY BOWEL DISEASES
- Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)
- (2012) Niklas Schmedt et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study
- (2011) Asit Parikh et al. INFLAMMATORY BOWEL DISEASES
- Assessment of JC virus DNA in blood and urine from natalizumab-treated patients
- (2010) Richard A. Rudick et al. ANNALS OF NEUROLOGY
- Progressive Multifocal Leukoencephalopathy and Newer Biological Agents
- (2010) Joseph R. Berger DRUG SAFETY
- Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians
- (2010) A. Antonsson et al. JOURNAL OF GENERAL VIROLOGY
- Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies
- (2009) Eugene O. Major Annual Review of Medicine
- Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents
- (2009) Carlo Piccinni et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
- (2009) D. Soler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now